Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3F7D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,390
Award facts
- Contract value 100% obligated
- $14,390.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens with a ceiling value of $14,390.25 under a firm fixed-price contract. The award was made on December 3, 2025, with an ultimate completion date of December 4, 2025. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. This is a non-set-aside delivery order, indicating the contract was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp has demonstrated significant capacity to fulfill federal medical procurement requirements, with this award reflecting the company's role as a critical vendor supporting Defense Health Agency and military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F3F7D?
SPE2DR26F3F7D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F3F7D worth?
The government has obligated $14,390 on SPE2DR26F3F7D.
Is contract SPE2DR26F3F7D an order under another contract?
Yes. SPE2DR26F3F7D is a delivery order under SPE2DR25D3001, an indefinite delivery contract.
Was contract SPE2DR26F3F7D competed?
The extent of competition for SPE2DR26F3F7D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award